CTRI/2024/05/067860尚未招募Unknown
Real-world safety assessment of SGLT2 inhibitors: an observational study in diverse patient population - NI
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- A
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients aged =18 years newly initiated on SGLT2 inhibitors as per standard protocol.
排除标准
- •1.Those patients who are already on SGLT2 inhibitors
- •2.Patients on cancer chemotherapy, retroviral drugs and glucocorticoids
- •3.Pregnant females and lactating mothers
- •4.Patients refusing to participate in the study
研究者
相似试验
招募中
不适用
Efficacy and safety of SGLT2 inhibitor in patients with diabetic kidneyDiabetic nephropathyJPRN-UMIN000031454ihon University40
已完成
不适用
Study of the safety of SGLT-2 inhibitors for heart failure patients with type 2 diabetes mellitusheart failure patients with type 2 diabetes mellitusJPRN-UMIN000018996ippon Medical School Department of Cardiovascular Medicine20
已完成
不适用
The efficacy and safety of SGLT2 inhibitor for non alcholic fatty liver disease in Japanese patients with type 2 diabetesJPRN-UMIN000016306Tokyo Medical and Dental University50
已完成
不适用
Efficacy and safety in SGLT2 inhibitor for non-diabetes complicated by non-alcoholic fatty liver disease/non-alcoholic steatohepatitis.JPRN-UMIN000031041Kobe university school of medicine, Diabetes and Endocrinoplogy30
招募中
不适用
Efficacy and Safety of SGLT2 inhibitors in patients with type 1 diabete.type 1 diabetesJPRN-UMIN000044317Hokkaido University Hospital200